Zur Hauptnavigation springen Zum Hauptinhalt springen Zur Fußzeile springen

Merger Notification - Announcement according to § 10 Cartel Act

Alps View Investment Pte. Ltd.; Novotech Health Holdings Pte. Ltd - BWB/Z-6911 | Bundeswettbewerbsbehörde

Alps View Investment Pte. Ltd.; Novotech Health Holdings Pte. Ltd

BWB/Z-6911

15.04.2025

On 14.04.2025 the Austrian Federal Competition Authority was notified of the following merger:

Planned purchase process

This notification concerns the proposed acquisition by Alps View Investment Pte. Ltd., Singapore of a non-controlling minority participation of approx. 11,9% of the shares in Novotech Health Holdings Pte. Ltd., Singapore. Together with shares already held by companies affiliated with Alps View, the participation in the target will exceed 25%. Novotech Health Holdings Pte. Ltd. and its worldwide subsidiaries are mainly active in the provision of Clinical Research
Organization (CRO) services.
ÖNACE Code:  Other human health activities n.e.c.

R - HUMAN HEALTH AND SOCIAL WORK ACTIVITIES R 86 - Human health activities, R 86.9 - Other human health activities, R 86.99 - Other human health activities n.e.c.

Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 12.05.2025.

Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.

Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.

Non-prohibition of the merger

The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 13.05.2025 .

back to list